Stocks

Indices

Home

Stocks

Astonea Labs Ltd.

The current prices were last updated on 19 Feb.

Download App

Astonea Labs Ltd.

₹155.00

+9.15 (6.27%)

Sector:

Healthcare

Industry:

Pharmaceuticals & Drugs

Healthcare

Pharmaceuticals & Drugs

NSE

BSE

The current prices were last updated on 19 Feb

Price

-3.09%

0.65%

9.08%

-13.89%

6.27%

Max

6.27%

-3.09%

0.65%

6.27%

Max

6.27%

Overview

Financials

Ratios

Peer Comparison

Shareholdings

FAQs

Astonea Labs Overview

155.00

Today's Low

155.00

Today's High

155.00

Open

Prev. Close

118.00

52W Low

185.00

52W High

P/E

Sector P/E

32.40

P/B

Sector P/B

3.07

Adj EPS

6.93

BVPS

23.85

OPM(%)

15.69

NPM(%)

5.49

ROE(%)

35.36

ROCE(%)

17.31

D/E

2.90

Div. Yld(%)

Astonea Labs Historical Returns

1 Day

0 %

1 Week

-3.09 %

1 Month

0.65 %

3 Month

9.08 %

6 Month

-13.89 %

1 Year

6.27 %

3 Year

6.27 %

5 Year

6.27 %

Max

6.27 %

Astonea Labs Financials

Profit & Loss

Balance Sheet

Cash Flow

*All values are in Rs. Cr

Consolidated

Unable to fetch the data

*All values are in Rs. Cr

Astonea Labs Financial Ratio

Unable to fetch the data

Astonea Labs Peer Comparison

Sector:

Healthcare

Industry:

Pharmaceuticals & Drugs

Returns

Financials

Ratios

Name	Industry	MarketCap (Cr)	Price	1D Returns	1W Returns	1M Returns	3M Returns	6M Returns	1Y Returns	3Y Returns	5Y Returns
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	0%	-3.09%	0.65%	9.08%	-13.89%	6.27%	6.27%	6.27%
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	-1.63%	-1.25%	6.64%	0.61%	-11.32%	22.39%	31.24%	11.58%
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	0.87%	-2.43%	1.42%	-55.45%	-58.86%	-45.47%	-28.36%	-43.11%
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	-1.83%	0.36%	-0.85%	4.66%	-6.65%	6.19%	636.89%	218.67%
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	0.60%	1.70%	8.49%	-1.06%	6.24%	29.55%	166.85%	143.85%
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	0.25%	1.27%	0.27%	-13.73%	-13.70%	-12.39%	87.19%	-14.78%

Name	Industry	MarketCap (Cr)	Price	Net Sales (Cr)	EBITDA (Cr)	EPS	Net Profit (Cr)	Book Value (Cr)
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	97.52	15.49	6.93	5.35	23.85
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	736.83	430.25	100.39	299.57	301.96
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	2,461.40	789.03	29.14	492.25	253.14
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	3,012.00	455.00	-2.90	-57.00	267.96
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	1,716.29	197.81	46.30	115.74	305.28
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	9,151.18	1,579.64	0.69	91.13	60.88

Name	Industry	MarketCap (Cr)	Price	PE	Industry PE	PB	Industry PB	Dividend Yield (%)	Debt To Equity
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	0	32.40	0	3.07	-	2.90
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	4.66	32.40	1.55	3.07	2.67	0
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	42.52	32.40	9.79	3.07	0.97	0
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	0	32.40	5.31	3.07	0	0.43
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	185.90	32.40	28.19	3.07	0.37	0
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	326.26	32.40	3.69	3.07	0.06	0.59

Astonea Labs Shareholding Pattern

Summary

Promoter

FII

MF

Public

Others

Astonea Labs Shareholding Breakup

*All values are in %

Unable to fetch the data

Astonea Labs FAQs

What is the current share price of Astonea Labs?

As of 19 Feb, the current share price of Astonea Labs is ₹155 per share.

What is the P/E ratio of Astonea Labs?

The Price-to-Earnings (P/E) ratio of Astonea Labs is 0. It is calculated based on its most recent quarterly earnings. The P/E ratio compares the company's current share price to its quarterly earnings per share (EPS), helping investors evaluate its market value relative to its earnings.

What is the EPS for Astonea Labs?

As reported in the latest quarterly financial statements, the Earnings Per Share (EPS) for Astonea Labs is ₹6.93. EPS is calculated by dividing the company's net income for the quarter by the number of outstanding shares, indicating how much profit is allocated to each share of stock during that period.

What is the ROE and ROCE of Astonea Labs?

As per latest financial reports, Astonea Labs has a Return on Equity (ROE) of 35.36% and a Return on Capital Employed (ROCE) of 17.31%. ROE measures the profitability relative to shareholders' equity, while ROCE assesses how efficiently the company utilizes its capital to generate profits.

What is the debt-to-equity ratio of Astonea Labs?

The debt-to-equity ratio of Astonea Labs is 2.90 according to its latest financial report. This ratio compares the company's total liabilities to its shareholder equity and is used to evaluate its financial leverage and risk level.

Loading Financial Data...

Similar stocks

SUNPHARMA

1722.00

NSE

-2.40

(0.14%)

DIVISLAB

6314.50

NSE

+31.00

(0.49%)

TORNTPHARM

4245.00

NSE

+34.20

(0.81%)

APOLLOHOSP

7630.00

NSE

-17.50

(0.23%)

CIPLA

1349.60

NSE

-0.20

(0.01%)

Excited to Trade?

Download CapMint and start your journey now!

Plot No 1290, 2nd Floor, 17th Cross, 5th Main, Sector-7, HSR Layout, Bangalore 560102

About us

All Stocks

Partners

Pricing

NIFTY Top 10

Reliance Industries Limited

Tata Consultancy Services Limited

HDFC Bank Limited

Bharti Airtel Limited

ICICI Bank Limited

Infosys Limited

State Bank of India

Hindustan Unilever Limited

Life Insurance Corporation Of India

ITC Limited

Links:

Download Centre

Investor Charters & Grievance Reports

Most Important Terms and Conditions

Advisory to Investors

Account Opening

Filing a Complaint

SMART ODR

IRRA

NCL Client Collateral

Terms and Conditions

Disclosures

Policies

FAQs

Corporate Governance

Risk Disclosure on Derivatives

RMS Policy

Referral Terms

About CapMint

Mintcap Brokers Private Limited
CIN – U66110KA2023PTC178706 | Registered Address: Plot No 1290, Second Floor, 17th Cross, 5th Main, Sector-7, HSR Layout, Bangalore 560102 | Tel: 080 – 49552310 | Email ID: compliance@capmint.com | SEBI registered Stock Broker: INZ000322732 | NSE Cash/F&O Member ID: 90430 | BSE Cash/F&O Member ID: 6903 | MCX Member ID: 57400 | NCDEX Member ID: 1312 | SEBI registered Depository Participant: IN-DP-806-2025 | CDSL DP ID: 12102300 | AMFI-Registered Mutual Fund Distributor: ARN-289109 (Valid upto 28-Feb-2027) | Category II Execution Only Platform : E6903

Details of Client Bank Account

Compliance Officer: Ms. Shridevi Vungarala | Email ID: compliance@capmint.com | Tel no. + 91 9035330126 | Grievance Redressal Officer (GRO) – Ms. Shikha Gupta | Email ID: Grievance@capmint.com | Tel no: 9035331595.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com > store > apps > sebiscores iOS: https://apps.apple.com > app > sebiscores

Disclaimer

Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit.
Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Mutual Funds are not exchange-traded products.

Attention Investor:

(1) Prevent Unauthorized Transactions in your trading account → Update your Mobile Number/email ID with your Stock broker. Receive alerts on your Registered Mobile/email ID for all debit and other important transactions in your demat account directly from Exchanges on the same day… issued in the interest of investors. | (2) Prevent Unauthorized Transactions in your demat account → Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day… issued in the interest of investors. | (3) KYC is a one-time exercise while dealing in securities markets — once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | (4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% as upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Astonea Labs Financials

Profit & Loss

Balance Sheet

Cash Flow

*All values are in Rs. Cr

Consolidated

Unable to fetch the data

*All values are in Rs. Cr

Astonea Labs Financial Ratio

Unable to fetch the data

Astonea Labs Peer Comparison

Sector:

Healthcare

Industry:

Pharmaceuticals & Drugs

Returns

Financials

Ratios

Name	Industry	MarketCap (Cr)	Price	1D Returns	1W Returns	1M Returns	3M Returns	6M Returns	1Y Returns	3Y Returns	5Y Returns
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	0%	-3.09%	0.65%	9.08%	-13.89%	6.27%	6.27%	6.27%
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	-1.63%	-1.25%	6.64%	0.61%	-11.32%	22.39%	31.24%	11.58%
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	0.87%	-2.43%	1.42%	-55.45%	-58.86%	-45.47%	-28.36%	-43.11%
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	-1.83%	0.36%	-0.85%	4.66%	-6.65%	6.19%	636.89%	218.67%
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	0.60%	1.70%	8.49%	-1.06%	6.24%	29.55%	166.85%	143.85%
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	0.25%	1.27%	0.27%	-13.73%	-13.70%	-12.39%	87.19%	-14.78%

Name	Industry	MarketCap (Cr)	Price	Net Sales (Cr)	EBITDA (Cr)	EPS	Net Profit (Cr)	Book Value (Cr)
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	97.52	15.49	6.93	5.35	23.85
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	736.83	430.25	100.39	299.57	301.96
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	2,461.40	789.03	29.14	492.25	253.14
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	3,012.00	455.00	-2.90	-57.00	267.96
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	1,716.29	197.81	46.30	115.74	305.28
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	9,151.18	1,579.64	0.69	91.13	60.88

Name	Industry	MarketCap (Cr)	Price	PE	Industry PE	PB	Industry PB	Dividend Yield (%)	Debt To Equity
Astonea Labs Ltd.	Pharmaceuticals & Drugs	162.92	155.00	0	32.40	0	3.07	-	2.90
Pfizer Ltd.	Pharmaceuticals & Drugs	23,558.94	5,065.90	4.66	32.40	1.55	3.07	2.67	0
Dr. Lal Pathlabs Ltd.	Hospital & Healthcare Services	23,549.02	1,417.70	42.52	32.40	9.79	3.07	0.97	0
Wockhardt Ltd.	Pharmaceuticals & Drugs	23,274.57	1,407.10	0	32.40	5.31	3.07	0	0.43
Astrazeneca Pharma India Ltd.	Pharmaceuticals & Drugs	22,222.13	8,939.50	185.90	32.40	28.19	3.07	0.37	0
Piramal Pharma Ltd.	Pharmaceuticals & Drugs	22,078.81	166.45	326.26	32.40	3.69	3.07	0.06	0.59

Astonea Labs Shareholding Pattern

Summary

Promoter

FII

MF

Public

Others

Astonea Labs Shareholding Breakup

*All values are in %